Acute lymphoblastic leukaemia trials in China

In China 169 Also abroad 564

169 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
Where
Suzhou
Age
15 years to 65 years
People
48
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06816134
Phase 1Not yet taking people in China
Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors
Where
Tianjin
Age
18 years to 69 years
People
9
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07539610
Phase 1/2Taking people
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
Where
Shenzhen
Age
18 years to 75 years
People
96
Run by
Beijing Biotech
See details and how to joinNCT07523555
No phaseEnrolling by invitation
The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
Where
Guangzhou
Age
5 years to 18 years
People
138
Run by
Sun Yat-sen University
See details and how to joinNCT07515430
Phase 1/2Taking people
Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
Where
Beijing
Age
12 years to 65 years
People
50
Run by
Peking University People's Hospital
See details and how to joinNCT06880913
Phase 2Taking people
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
Where
Suzhou
Age
15 years and over
People
26
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06985485
Phase 1Not yet taking people in China
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
Where
Fuzhou
Age
14 years and over
People
6
Run by
Fujian Medical University
See details and how to joinNCT07491263
Phase 2Taking people
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
Where
Suzhou
Age
15 years and over
People
28
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05376111
No phaseNot yet taking people in China
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Where
Hangzhou, Ningbo
Age
1 year to 21 years
People
400
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07483749
Early phase 1Taking people
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults
Where
Wuhan
Age
12 years to 75 years
People
18
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470073
Phase 1/2Taking people
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
Where
Beijing, Chengdu, Shanghai
Age
1 year to 70 years
People
54
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06316856
No phaseTaking people
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
Where
Beijing
Age
1 year to 70 years
People
353
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06343090
Early phase 1Taking people
Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia
Where
Beijing
Age
18 years to 70 years
People
3
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06890494
No phaseNot yet taking people in China
NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy
Where
Hangzhou
Age
1 year to 18 years
People
110
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07462299
Phase 1Taking people
Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial
Where
Beijing
Age
1 year to 18 years
People
48
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06326008
No phaseTaking people
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
Where
Tianjin
Age
18 years and over
People
82
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06481228
No phaseTaking people
Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
Where
Tianjin
Age
18 years and over
People
77
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06481241
Phase 3Taking people
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Where
Beijing
Age
3 years to 79 years
People
70
Run by
Peking University People's Hospital
See details and how to joinNCT07441291
No phaseTaking people
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
Where
Beijing
Age
1 year to 39 years
People
213
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06389305
Early phase 1Taking people
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia
Where
Hangzhou
Age
18 years to 75 years
People
16
Run by
Zhejiang University
See details and how to joinNCT07429461
Phase 1/2Taking people
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
Where
Changchun, Dalian, Guangzhou, Guiyang, Hangzhou, Kunming, Nanchang, Shenyang, Xuzhou, Zhengzhou
Age
18 years to 75 years
People
46
Run by
Excyte Biopharma Ltd
See details and how to joinNCT06580301
No phaseTaking people
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Where
Shanghai, Shenzhen, Zhengzhou
Age
8 years to 17 years
People
173
Run by
The Hong Kong Polytechnic University
See details and how to joinNCT07326930
Early phase 1Taking people
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
Where
Kunming
Age
Up to 75 years
People
20
Run by
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT06514768
No phaseNot yet taking people in China
Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia
Where
Zhengzhou
Age
10 years to 17 years
People
60
Run by
The Hong Kong Polytechnic University
See details and how to joinNCT07319481
No phaseTaking people
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Where
Beijing
Age
Up to 18 years
People
283
Run by
Peking University People's Hospital
See details and how to joinNCT06452732